Compositions and methods for inferring an adverse effect in response to a drug treatment

Details for Australian Patent Application No. 2005304645 (hide)

Owner DNAPrint Genomics, Inc.

Inventors Frudakis, Tony

Agent Freehills

Pub. Number AU-A-2005304645

PCT Pub. Number WO2006/053322

Priority 60/627,453 12.11.04 US

Filing date 14 November 2005

Wipo publication date 18 May 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12P 19/34 (2006.01) Preparation of compounds containing saccharide radicals

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/053322 Priority application(s): WO2006/053322

9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005304646-Inhibitors of HIV-1 capsid formation: substituted aryl aminomethyl thiazole ureas and analogues thereof

2005304638-Methods and compositions for treating cellular proliferative diseases